Thaddeus J. Unger
Publications by Year
Research Areas
Nuclear Structure and Function, Multiple Myeloma Research and Treatments, PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → Selective Deletion ofBdnfin the Ventromedial and Dorsomedial Hypothalamus of Adult Mice Results in Hyperphagic Behavior and Obesity(2007)370 cited
- → First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors(2016)246 cited
- → Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma(2016)163 cited
- → Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma(2017)156 cited
- → A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia(2017)149 cited
- → Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma(2018)137 cited
- → Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia(2017)134 cited
- → Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death(2016)129 cited
- → Examination of behavioral deficits triggered by targeting BDNF in fetal or postnatal brains of mice(2006)125 cited
- → Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma(2018)117 cited